RSS feed

Publications (original articles or review articles) published in 2023 from OUS - Department of Haematology

9 publications found

Dusingizimana T, Ramilan T, Weber JL, Iversen PO, Mugabowindekwe M, Ahishakiye J, Brough L (2023)
Predictors for achieving adequate antenatal care visits during pregnancy: a cross-sectional study in rural Northwest Rwanda
BMC Pregnancy Childbirth, 23 (1), 69
DOI 10.1186/s12884-023-05384-0, PubMed 36703102

Enden T (2023)
In training or at work?
Tidsskr Nor Laegeforen, 143 (2)
DOI 10.4045/tidsskr.23.0031, PubMed 36718885

IRF4 International Consortium, Fornes O, Jia A, Kuehn HS, Min Q, Pannicke U, Schleussner N, Thouenon R, Yu Z, de Los Angeles Astbury M, Biggs CM, Galicchio M, Garcia-Campos JA, Gismondi S, Gonzalez Villarreal G, Hildebrand KJ, Hönig M, Hou J, Moshous D, Pittaluga S, Qian X, Rozmus J, Schulz AS, Staines-Boone AT, Sun B et al. (2023)
A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency
Sci Immunol, 8 (79), eade7953
DOI 10.1126/sciimmunol.ade7953, PubMed 36662884

Matlary RED, Grydeland M, Glosli H, Rueegg CS, Holme PA (2023)
Physical activity in Norwegian teenagers and young adults with haemophilia A compared to general population peers
Haemophilia (in press)
DOI 10.1111/hae.14752, PubMed 36723510

Plesner T, Harrison SJ, Quach H, Lee C, Bryant A, Vangsted A, Estell J, Delforge M, Offner F, Twomey P, Choeurng V, Li J, Hendricks R, Ruppert SM, Sumiyoshi T, Miller K, Cho E, Schjesvold F (2023)
Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma
Clin Hematol Int (in press)
DOI 10.1007/s44228-022-00023-5, PubMed 36656461

Roman G, Stavik B, Lauritzen KH, Sandset PM, Harrison SP, Sullivan GJ, Chollet ME (2023)
"iPSC-derived liver organoids and inherited bleeding disorders: Potential and future perspectives"
Front Physiol, 14, 1094249
DOI 10.3389/fphys.2023.1094249, PubMed 36711019

Tislevoll BS, Hellesøy M, Fagerholt OHE, Gullaksen SE, Srivastava A, Birkeland E, Kleftogiannis D, Ayuda-Durán P, Piechaczyk L, Tadele DS, Skavland J, Panagiotis B, Hovland R, Andresen V, Seternes OM, Tvedt THA, Aghaeepour N, Gavasso S, Porkka K, Jonassen I, Fløisand Y, Enserink J, Blaser N, Gjertsen BT (2023)
Early response evaluation by single cell signaling profiling in acute myeloid leukemia
Nat Commun, 14 (1), 115
DOI 10.1038/s41467-022-35624-4, PubMed 36611026

Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M et al. (2023)
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
Crit Care, 27 (1), 9
DOI 10.1186/s13054-022-04205-8, PubMed 36627655

Ågnes C, Schwartz T, Quist-Paulsen E, Bhatti R, Njaastad AM, Fuglestved J, Wibetoe G (2023)
Drug-induced aseptic meningitis
Tidsskr Nor Laegeforen, 143 (1)
DOI 10.4045/tidsskr.22.0286, PubMed 36655954